Walleye Trading’s BeOne Medicines Ltd ONC Stock Holding History

Walleye Trading’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$89.9K	–	5577
2023 Q3	$89.9K	Sell	500 -2,300	-82%	-$455K	﹤0.01%	4013
2023 Q2	$499K	Sell	2,800 -5,700	-67%	-$1.31M	﹤0.01%	2746
2023 Q1	$1.83M	Buy	8,500 +7,700	+963%	+$1.85M	﹤0.01%	1751
2022 Q4	$176K	Buy	+800	New	+$147K	﹤0.01%	3672
2021 Q4	–	Sell	-600	Closed	-$218K	–	5992
2021 Q3	$218K	Buy	+600	New	+$196K	﹤0.01%	3767
2020 Q3	–	Sell	-4,600	Closed	-$867K	–	4710
2020 Q2	$867K	Buy	+4,600	New	+$749K	0.01%	1786
2019 Q4	–	Sell	-200	Closed	-$24K	–	4700
2019 Q3	$24K	Buy	+200	New	+$26.6K	﹤0.01%	3736
2019 Q1	–	Sell	-6,300	Closed	-$884K	–	4886
2018 Q4	$884K	Buy	6,300 +3,600	+133%	+$477K	0.01%	1853
2018 Q3	$465K	Buy	+2,700	New	+$454K	﹤0.01%	2975

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Walleye Trading's ONC Position: Q4 2023 in Review

Walleye Trading sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 224 shares — an estimated $40.3K sold.

Walleye Trading first reported a position in ONC in Q3 2018 and held it in 4 quarters. The position peaked at $163K in Q4 2019. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

Walleye Trading reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
Walleye Trading sold 224 BeOne Medicines Ltd shares in Q4 2023, an estimated $40.3K.
Walleye Trading first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 4 quarters.
Walleye Trading's BeOne Medicines Ltd position peaked at $163K in Q4 2019.
204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.